Incorporating Manufacturability as an Early Checkpoint for Design and Selection of Scalable Vector Designs

Time: 12:00 pm
day: Day One AM


• Why scalability and manufacturability represent some of the largest issues faced in the development of Gene Therapies

• How incorporating manufacturability in vector designs can enable seamless upscaling to large scale production

• How vector design can enable increased productivity of the production process with regard to yields (titer) and quality (percentage full capsids)

• Increasing collaboration between early design and CMC teams to smoothen downstream transitions